Type I leucocyte adhesion deficiency (LAD I). Report of a case

被引：1
|
作者：
Garcia, M. B. [1 ]
Dominguez, O. [1 ]
Juan, M. [2 ]
Arostegui, J. I. [2 ]
Badell, I. [3 ]
Chapman, E. [1 ]
Martin-Mateos, M. A. [1 ]
机构：
[1] Univ Barcelona, Sect Immunol & Pediat Allergy, St Joan de Deu Hosp, E-08007 Barcelona, Spain
[2] Univ Barcelona, Dept Immunol, Clin Hosp, E-08007 Barcelona, Spain
[3] Autonomous Univ Barcelona, Transplant Unit, St Pau Hosp, Barcelona, Spain
来源：
ALLERGOLOGIA ET IMMUNOPATHOLOGIA | 2012年 / 40卷 / 04期
关键词：
MOLECULAR-BASIS; TRANSPLANTATION; DEFECTS;
D O I：
10.1016/j.aller.2011.05.013
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：254 / 258
页数：5
相关论文
共 50 条
  • [1] Neutrophil Function in a Leucocyte Adhesion Deficiency Type I (LAD I) Patient
    Perez, L.
    Regairaz, L.
    Bustamante, J.
    Garcia, M.
    Cabanillas, D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S261 - S262
  • [2] Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I
    Eyerich, Kilian
    Cifaldi, Loredana
    Notarangelo, Lucia Dora
    Porta, Fulvio
    Notarangelo, Luigi
    Mazzolari, Evelina
    Fiorini, Maurila
    Paradisi, Andrea
    Cavani, Andrea
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (01) : 78 - 79
  • [3] Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: A case series
    Cantisani, Carmen
    Naqeshbandi, Ahmad Faiq
    Goldust, Mohamad
    Lampitelli, Salvatore
    Cantoresi, Franca
    Alsorori, Ezeldeen
    DERMATOLOGIC THERAPY, 2019, 32 (03)
  • [4] Comprehensive preclinical studies for the gene therapy of patients with leukocyte adhesion deficiency type I (LAD-I)
    Almarza, E.
    Mesa-Nunez, C.
    Damian, C.
    Diez-Cabezas, B.
    Fernandez-Garcia, M.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A28 - A28
  • [5] New Lentiviral Vectors for the Gene Therapy of Human Leucocyte Adhesion Deficiency Type I
    Leon-Rico, D.
    Aldea, M.
    Sanchez, R.
    Thrasher, A. J.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2014, 25 (11) : A111 - A111
  • [6] Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation?
    Fekadu, Julia
    Modlich, Ute
    Bader, Peter
    Bakhtiar, Shahrzad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [7] Leukocyte Adhesion Deficiency-I (LAD-I): A Comprehensive Review of Published Cases
    Kasbekar, Sanchali
    Bueren, Juan
    Thrasher, Adrian J.
    Kohn, Donald B.
    Sevilla, Julian
    Schwartz, Jonathan D.
    Almarza, Elena
    BLOOD, 2017, 130
  • [8] Regulated CD18 expression in the haematopoietic gene therapy of leukocyte adhesion deficiency type I (LAD-I)
    Mesa-Nunez, C.
    Damian, C.
    Leon-Rico, D.
    Aldea, M.
    Thrasher, A. J.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A22 - A22
  • [9] Gene Therapy of Patients with Leukocyte Adhesion Deficiency Type I (LAD-I): Preclinical Studies and Clinical Trial Design
    Almarza, Elena
    Mesa-Nunez, Cristina
    Damian, Carlos
    Diez-Cabezas, Begona
    Fernandez-Garcia, Maria
    Lozano, MLuz
    Rio, Paula
    Yanez, Rosa M.
    Beard, Brian
    Sevilla, Julian
    Schwartz, Jonathan D.
    Bueren, Juan A.
    MOLECULAR THERAPY, 2019, 27 (04) : 392 - 392
  • [10] Allogenic bone marrow transplantation (BMT) in patients with leucocyte adhesion deficiency (LAD).
    Farinha, NJ
    Champagne, J
    Lapointe, N
    Barrette, S
    Tapiero, B
    Busque, L
    Champagne, MA
    BLOOD, 2001, 98 (11) : 676A - 676A
12345